Genomic characterization of colistin heteroresistance in Acinetobacter baumannii : Evidence for lpxD deletion and collateral sensitivity
Journal of Antimicrobial Chemotherapy · 2026
DOI: 10.1093/jac/dkag076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Banu Sancak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Colistin, Acinetobacter baumannii, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Ankara Yıldırım Beyazıt University's Research Foundation, Ankara Yıldırım Beyazıt University’s Research Foundation.
Abstract (Originalsprache)
Objectives
To search for colistin heteroresistance (CHR) prevalence in Acinetobacter baumannii bloodstream isolates, and to investigate potential molecular contributors to CHR using WGS.
Methods
A total of 267 A. baumannii isolates were recovered from bloodstream infections between January 2014 and July 2018 at a tertiary care hospital in Türkiye. Antimicrobial susceptibility to colistin was assessed using the broth microdilution method. CHR was evaluated by population analysis profiling (PAP). WGS was performed on a representative heteroresistant strain (A325) to investigate putative CHR-associated mechanisms.
Results
Thirty-five isolates (13.9%) were classified as colistin-resistant. CHR was identified in 86 of 267 isolates (32.2%) using PAP. Comparative genomic analysis of the colistin-susceptible main population and the colistin-resistant subpopulation of isolate A325 revealed identical mutational profiles in known resistance-associated genes, with the exception of a partial deletion in the lpxD gene between codons 2 and 75, identified exclusively in the resistant subpopulation. Notably, tetracyclines, macrolides and aminoglycosides were fully inactive in the colistin-susceptible main population, whereas an inhibition zone around these antibiotic discs was observed with the colistin-resistant subpopulation.
Conclusions
This study demonstrates a high prevalence of both colistin resistance and CHR among A. baumannii bloodstream isolates. The identification of a partial lpxD deletion in the resistant subpopulation of the colistin-heteroresistant isolate suggests a potential contributory role of LPS-related alterations in CHR. Inverse antimicrobial activity profiles between populations highlight distinct resistance mechanisms potentially shaped by evolutionary trade-offs and collateral sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- Department of Medical Microbiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
- Central Research and Application Center, Ankara Yildirim Beyazit University, Ankara, Turkey.
- Department of Medical Microbiology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
ORCID-Profile: Banu Sancak, Ekin Kırbaş, Oguz Ari, Rıza Durmaz
Förderung
- Ankara Yıldırım Beyazıt University's Research Foundation
- Ankara Yıldırım Beyazıt University’s Research Foundation
Zitieren
APA
Sancak, B., Kırbaş, E., Ari, O., & Durmaz, R. (2026). Genomic characterization of colistin heteroresistance in Acinetobacter baumannii : Evidence for lpxD deletion and collateral sensitivity. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag076
Vancouver
Sancak B, Kırbaş E, Ari O, Durmaz R. Genomic characterization of colistin heteroresistance in Acinetobacter baumannii : Evidence for lpxD deletion and collateral sensitivity. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag076
BibTeX
@article{Sancak2026,
author = {Sancak, Banu and Kırbaş, Ekin and Ari, Oguz and Durmaz, Rıza},
title = {Genomic characterization of colistin heteroresistance in Acinetobacter baumannii : Evidence for lpxD deletion and collateral sensitivity},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
doi = {10.1093/jac/dkag076}
}
EUVIMED